Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin.

Salloum D, Mukhopadhyay S, Tung K, Polonetskaya A, Foster DA. Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin. Mol Cancer Ther. 2014 Mar; 13(3):733-41.

View in: PubMed

subject areas

Animals
Cell Proliferation
Cell Survival
Humans
Lipids
Multiprotein Complexes
Mutation
ras Proteins

authors with profiles

David A. Foster

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support